A new oral amoebicid (RO 7-0207) in the treatment of intestinal amoebiasis.
D000433:1-Propanol / Q000627:therapeutic use*; D000284:Administration, Oral; D000563:Amebicides / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004404:Dysentery, Amebic / Q000188:drug therapy*; D004748:Entamoeba histolytica / Q000302:isolation & purification*; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000627:therapeutic use*; D013997:Time Factors
D000563:Amebicides; D009593:Nitroimidazoles; D008795:Metronidazole; D000433:1-Propanol